Fidelity Investments’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.84B Buy
45,440,355
+924,345
+2% +$108M 0.25% 57
2026
Q1
$5.35B Buy
44,516,010
+3,679,444
+9% +$425M 0.28% 46
2025
Q4
$4.3B Buy
40,836,566
+7,409,816
+22% +$696M 0.22% 60
2025
Q3
$2.81B Buy
33,426,750
+1,860,625
+6% +$153M 0.15% 113
2025
Q2
$2.5B Sell
31,566,125
-241,918
-0.8% -$19.2M 0.14% 111
2025
Q1
$2.86B Sell
31,808,043
-5,552,529
-15% -$518M 0.18% 80
2024
Q4
$3.72B Sell
37,360,572
-12,345,732
-25% -$1.27B 0.22% 60
2024
Q3
$5.64B Sell
49,706,304
-946,950
-2% -$113M 0.34% 36
2024
Q2
$6.27B Sell
50,653,254
-1,517,665
-3% -$195M 0.4% 30
2024
Q1
$6.88B Buy
52,170,919
+9,370,902
+22% +$1.16B 0.46% 28
2023
Q4
$4.67B Buy
42,800,017
+4,654,819
+12% +$483M 0.36% 40
2023
Q3
$3.93B Sell
38,145,198
-819,448
-2% -$88.3M 0.34% 44
2023
Q2
$4.5B Buy
38,964,646
+3,229,721
+9% +$367M 0.38% 39
2023
Q1
$3.8B Buy
35,734,925
+8,281,942
+30% +$894M 0.35% 45
2022
Q4
$3.05B Buy
27,452,983
+4,255,943
+18% +$435M 0.3% 62
2022
Q3
$2B Buy
23,197,040
+847,491
+4% +$75.7M 0.21% 81
2022
Q2
$2.04B Buy
22,349,549
+7,816,470
+54% +$693M 0.2% 86
2022
Q1
$1.19B Buy
14,533,079
+463,078
+3% +$36.5M 0.1% 186
2021
Q4
$1.08B Buy
14,070,001
+3,382,119
+32% +$269M 0.08% 222
2021
Q3
$803M Buy
10,687,882
+330,009
+3% +$25.1M 0.06% 285
2021
Q2
$806M Buy
10,357,873
+3,868,334
+60% +$288M 0.06% 282
2021
Q1
$477M Sell
6,489,539
-1,496,370
-19% -$110M 0.04% 444
2020
Q4
$623M Sell
7,985,909
-4,736,522
-37% -$362M 0.06% 337
2020
Q3
$1.01B Sell
12,722,431
-857,189
-6% -$67.1M 0.1% 179
2020
Q2
$1B Buy
13,579,620
+43,708
+0.3% +$3.29M 0.11% 169
2020
Q1
$994M Buy
13,535,912
+450,350
+3% +$35.4M 0.14% 136
2019
Q4
$1.14B Buy
13,085,562
+862,461
+7% +$70.8M 0.13% 153
2019
Q3
$982M Buy
12,223,101
+710,780
+6% +$57M 0.12% 175
2019
Q2
$921M Sell
11,512,321
-132,472
-1% -$10.1M 0.11% 185
2019
Q1
$924M Buy
11,644,793
+3,399,793
+41% +$254M 0.11% 174
2018
Q4
$601M Buy
8,245,000
+3,139,388
+61% +$222M 0.08% 231
2018
Q3
$346M Sell
5,105,612
-173,439
-3% -$11M 0.04% 455
2018
Q2
$306M Buy
5,279,051
+165,157
+3% +$9.32M 0.04% 490
2018
Q1
$266M Sell
5,113,894
-1,160,569
-18% -$62.7M 0.03% 570
2017
Q4
$337M Sell
6,274,463
-6,024,691
-49% -$334M 0.04% 484
2017
Q3
$751M Sell
12,299,154
-1,466,052
-11% -$88.9M 0.09% 226
2017
Q2
$842M Buy
13,765,206
+179,638
+1% +$10.9M 0.1% 208
2017
Q1
$824M Sell
13,585,568
-550,570
-4% -$33.4M 0.1% 204
2016
Q4
$794M Sell
14,136,138
-126,467
-0.9% -$7.4M 0.11% 201
2016
Q3
$849M Sell
14,262,605
-9,177
-0.1% -$537K 0.11% 194
2016
Q2
$785M Buy
14,271,782
+733,178
+5% +$39M 0.11% 197
2016
Q1
$684M Buy
13,538,604
+1,499,441
+12% +$73.4M 0.09% 220
2015
Q4
$607M Buy
12,039,163
+1,433,677
+14% +$72.3M 0.08% 251
2015
Q3
$500M Sell
10,605,486
-799,382
-7% -$42.5M 0.07% 303
2015
Q2
$620M Sell
11,404,868
-6,060,271
-35% -$340M 0.08% 279
2015
Q1
$958M Sell
17,465,139
-2,574,833
-13% -$146M 0.12% 173
2014
Q4
$1.09B Sell
20,039,972
-15,468,412
-44% -$862M 0.14% 153
2014
Q3
$2.01B Sell
35,508,384
-15,476,246
-30% -$869M 0.27% 70
2014
Q2
$2.81B Sell
50,984,630
-11,411,444
-18% -$623M 0.38% 45
2014
Q1
$3.38B Buy
62,396,074
+6,567,190
+12% +$340M 0.47% 38
2013
Q4
$2.67B Sell
55,828,884
-8,435,595
-13% -$386M 0.38% 48
2013
Q3
$2.92B Sell
64,264,479
-13,404,177
-17% -$612M 0.45% 37
2013
Q2
$3.44B Buy
+77,668,656
New +$3.47B 0.56% 26

Other funds holding MRK

Fidelity Investments's MRK Position: Q2 2026 in Review

Fidelity Investments increased its Merck (MRK) stake by 2.1% in Q2 2026, buying an estimated $108M and bringing the position to 45,440,355 shares worth $5.84B. The position accounts for 0.25% of the portfolio, ranked #57.

Fidelity Investments first reported a position in MRK in Q2 2013 and has held it in 53 quarters since. The position peaked at $6.88B in Q1 2024. 3,813 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Fidelity Investments held 45,440,355 shares of Merck worth $5.84B as of Q2 2026.
  • Fidelity Investments bought 924,345 Merck shares in Q2 2026, an estimated $108M.
  • Merck made up 0.25% of Fidelity Investments's portfolio in Q2 2026, its #57 holding.
  • Fidelity Investments first reported a position in Merck in Q2 2013 and has held it in 53 quarters since.
  • Fidelity Investments's Merck position peaked at $6.88B in Q1 2024.
  • 3,813 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Fidelity Investments's 13F filing for Q2 2026, filed 13 Aug 2026.